portablegenomics.org

Company Snapshot

Founded: 2013
Entity Type: Private
Region: U.S.
Headquarter: California, U.S.
Key Geographics: U.S.
Corporate Address: 3210 Merryfield Row San Diego, California 92121 U.S. www.portablegenomics.org

Company Overview

Portable Genomics develops software for the visualization of personal genomic data on smartphones or tablets. The company’s objective is to make sequencing data visual and easy for people to share with their doctors. The approach is to arrange sequencing data into an mp3 structure, as well as to create a file that can be stored or shared as digital music and read by iTunes or similar software. The intent is to be able to use this information on mp3 players, iPods, digital TVs and cloud-based digital music services.

Portable Genomics launched its first product, SaveMy23, in 2014. SaveMy23 allows 23andMe data owners to download and save their genetic data on an iPhone or iPad device.

In January 2017 Portable Genomics formed a partnership with CFTechnology.org to develop a health management platform for cystic fibrosis (CF) patients. The companies will develop a mobile platform for collecting and aggregating data to aid CF patients as well as for use in the drug discovery process.

Portable Genomics is developing an app, called NuMe, which will allow patients to combine genotype and phenotype results and health and lifestyle information on a mobile device. The sales model for this app calls for Portable Genomics to share revenues with the consumer for allowing research organizations to access a consumer’s personal data.

portablegenomics.org In Reports

Global DNA Read, Write and Edit Market

The global market for DNA read, write and edit applications should grow from $17.0 billion in 2019 to $43.1 billion by 2024 with a compound annual growth rate of 20.5% during the period of 2019-2024.

Liquid Biopsy with Emphasis on Cancer: Global Markets to 2023

Get an overview of the global markets for liquid biopsy technologies, applications, industry subsegments along with analyses of global market trends with data from 2017, 2018 and projections of CAGRs through 2023 ...

Global DNA Sequencing: Research, Applied and Clinical Markets

The global DNA sequencing market was $10.7 billion in 2018 and is forecast to increase at a compound annual growth rate of 18.0% to reach $24.4 billion in 2023.

Company's Business Segments

  • Portable Genomics : This segment includes to Curate Portable Genomics tools that can be used in field settings, to promote a discovery service for IP Development, in the Genotype to Phenotype Space.

Applications/End User Industries

  • Healthcare
  • Genomics
  • Data Mining
  • Genotype to Phenotype correlations
  • Portable Genomics
  • Life Sciences
AI Sentiment